AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 0.42 |
Market Cap | 22.46M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -8.31 |
PE Ratio (ttm) | -0.05 |
Forward PE | n/a |
Analyst | n/a |
Ask | 0.44 |
Volume | 2,438,001 |
Avg. Volume (20D) | 10,721,727 |
Open | 0.43 |
Previous Close | 0.45 |
Day's Range | 0.40 - 0.50 |
52-Week Range | 0.22 - 2.63 |
Beta | undefined |
About ERNA
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics,...
3 years ago · investorplace.com
BTX Stock: The Big News That Has Brooklyn ImmunoTherapeutics Rocketing HigherToday, investors in BTX stock appear to be on board in a big way with a major announcement from this hot meme stock and Reddit favorite. The post BTX Stock: The Big News That Has Brooklyn ImmunoTherap...